In a patient with obstructive sleep apnea (OSA) using continuous positive airway pressure (CPAP) who has a markedly elevated hematocrit, could OSA alone cause such a high hematocrit, or should other causes be evaluated?

OSA Can Cause Elevated Hematocrit, But Rarely to Polycythemia Levels—Investigate Other Causes

OSA alone typically causes only modest elevations in hematocrit (HCT) and hemoglobin (HGB), and true polycythemia from OSA is uncommon (prevalence ~2% overall, 6% in severe OSA). If your patient has markedly elevated HCT/HGB, you should actively evaluate for other causes of secondary polycythemia rather than attributing it solely to OSA 1, 2.

Understanding the OSA-Hematocrit Relationship

Expected Elevations Are Modest

Recent evidence demonstrates that while OSA patients have statistically higher hematocrit levels compared to controls, the absolute increases are clinically small:

• Moderate OSA patients show HCT levels around 42.3% versus 40.3% in non-OSA patients—a difference of only ~2% 2
• Severe OSA patients (AHI >30) have significantly higher HCT than mild-moderate OSA, but >98% of OSA patients do not develop elevated hemoglobin meeting polycythemia criteria 3
• Mean values typically remain within normal reference ranges despite statistical differences 2

Why OSA Doesn't Cause Expected Erythrocytosis

The intermittent hypoxia in OSA should theoretically stimulate robust erythropoiesis, but multiple compensatory mechanisms prevent this 3:

• Neocytolysis: Newly formed red blood cells generated during hypoxic episodes undergo lysis when oxygen levels normalize, creating a cycle of production and destruction
• Increased reactive oxygen species: Expanded reticulocyte mitochondria produce ROS that damage young RBCs
• Inflammation-mediated suppression: Elevated hepcidin from chronic inflammation limits iron availability for erythropoiesis
• MicroRNA-21 effects: Downregulates catalase (an antioxidant), making cells more vulnerable to oxidative damage

These mechanisms explain why red cell mass measurements (by radionuclide labeling) remain normal in OSA patients despite intermittent hypoxia 3.

Clinical Predictors of Higher Hematocrit in OSA

When HCT elevations do occur in OSA, they correlate with specific parameters 4, 5:

• Severity markers: Higher oxygen desaturation index (ODI), lower minimum SpO2, greater percentage of time with SpO2 <90%
• Mean oxygen saturation: Inverse correlation (lower mean SpO2 = higher HCT)
• AHI severity: Respiratory disturbance index independently predicts HCT even after controlling for confounders
• Body habitus: Higher BMI shows positive correlation

Critical point: Even with these associations, only 1 patient out of 263 in one study had HCT in the clinical polycythemia range 4.

What to Do When HCT/HGB Are Markedly Elevated

Evaluate for Alternative Causes

Since OSA rarely causes true polycythemia, investigate:

• Chronic lung disease (COPD, interstitial lung disease)
• Cardiac right-to-left shunts
• High-altitude exposure or residence
• Smoking history (carboxyhemoglobin)
• Renal pathology (inappropriate erythropoietin production)
• Polycythemia vera (JAK2 mutation testing if appropriate)
• Testosterone supplementation or anabolic steroid use
• Dehydration (check if elevated HCT/HGB with normal red cell mass)

Measure Red Cell Mass

If polycythemia is confirmed by elevated HCT/HGB, consider direct red cell mass measurement (radionuclide labeling or carbon monoxide inhalation method) to distinguish true polycythemia from relative polycythemia due to plasma volume contraction 3.

Effect of CPAP on Hematocrit

CPAP Reduces HCT, But Modestly

Meta-analysis of CPAP treatment effects shows 1:

• Hemoglobin reduction: 3.76 g/L (95% CI: -4.73 to -2.80 g/L)
• Hematocrit reduction: 1.1% (95% CI: -1.4% to -0.9%)

These reductions are statistically significant but clinically small. If your patient's HCT was markedly elevated before CPAP and remains high despite adherent CPAP use, this strongly suggests an alternative etiology 1.

CPAP Effects on Pulmonary Hemodynamics

While not directly about HCT, it's worth noting that CPAP reduces mild pulmonary hypertension associated with OSA (mean PAP decreases from ~17-25 mm Hg to ~12-20 mm Hg), which could theoretically affect erythropoietic drive 6. However, this effect is modest and doesn't explain marked polycythemia.

Common Pitfalls to Avoid

1. Assuming OSA explains marked polycythemia: The evidence clearly shows OSA causes minimal HCT elevation in most patients
2. Not measuring red cell mass: Relative polycythemia (dehydration, diuretics) can masquerade as true polycythemia
3. Ignoring comorbid lung disease: Spirometric abnormalities strongly associate with higher HCT in OSA patients 6
4. Expecting CPAP to normalize marked polycythemia: CPAP's effect on HCT is modest; persistent elevation warrants further investigation

Bottom Line Algorithm

For OSA patients with elevated HCT/HGB:

1. Mild elevation (HCT 45-48% in men, 42-45% in women): Likely attributable to OSA if severe disease with significant nocturnal hypoxemia; optimize CPAP therapy
2. Moderate-marked elevation (HCT >48% in men, >45% in women): Pursue alternative diagnoses aggressively—OSA alone rarely causes this
3. Check: Spirometry, arterial blood gas, smoking history, medication review, renal function, consider JAK2 mutation
4. Consider: Red cell mass measurement if diagnosis unclear
5. Monitor: HCT after 3-6 months of adherent CPAP; lack of improvement suggests non-OSA etiology

2, 5, 3, 1, 4